Clinical Trial: A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia(R)

U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07062978) titled 'A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia(R)' on July 03.

Brief Summary: This study is a multicenter, randomized, double-blind comparative study to valuating the efficacy and safety of QL1206 and Prolia(R) in postmenopausal women with osteoporosis at high risk of fracture.

Study Start Date: June 27

Study Type: INTERVENTIONAL

Condition: Postmenopausal Women With Osteoporosis at High Risk of Fracture

Intervention: DRUG: QL1206

QL1206 Denosumab injection(60 mg) was administered subcutaneously once every 6 months for a maximum of 2 consecutive doses throughout the trial.

DRUG: Prolia(R)

Proli...